| A0A8D0QGU4 |
Rho-associated protein kinase |
K716 |
ELLKQKDVLNEDVRNLTLKIEQETQKRCLTQNDLKMQTQQVNTLKMSEKQL |
| A0A8D0QGU4 |
Rho-associated protein kinase |
K798 |
MKELQDQLEAEQYFSTLYKTQVRELKEECEEKTKLCKELQQKKQELQDERD |
| A0A8D0QGU4 |
Rho-associated protein kinase |
K809 |
QYFSTLYKTQVRELKEECEEKTKLCKELQQKKQELQDERDSLAAQLEITLT |
| A0A8D0QGU4 |
Rho-associated protein kinase |
K815 |
YKTQVRELKEECEEKTKLCKELQQKKQELQDERDSLAAQLEITLTKADSEQ |
| A0A8D0QIL0 |
Adenylate kinase 2, mitochondrial |
K30 |
VTASEPAQEGPKGIRAVLLGPPGAGKGTQAPRLAENFCVCHLATGDMLRAM |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K160 |
GLFSQILQGEDIVRERAIKFLSTKLKTLPDEVLTKEVEELILTESKKVLED |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K251 |
TFNPSDPDCVDRLLQCTRQAVPLFSKNVHSTRFVTYFCEQVLPNLSSLTTP |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K398 |
FKIRLQYFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINV |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K404 |
YFARGLQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIKDLF |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K409 |
LQVYIRQLRLALQGKTGEALKTEENKIKVVALKITNNINVLIKDLFHIPPS |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K448 |
VLIKDLFHIPPSYKSTVTLSWKPVQKVEIGQKRANEDTTSGSPPKKPPTGP |
| A0A8D0QM65 |
Apoptosis inhibitor 5 |
K454 |
FHIPPSYKSTVTLSWKPVQKVEIGQKRANEDTTSGSPPKKPPTGPKRDARQ |
| A0A8D0QPG4 |
- |
K16 |
**********IAALDPNLKRRVNALKNLQVKCAQIEAKFYEEVHDLERKYA |
| A0A8D0QPG4 |
- |
K200 |
DSDPFSFDGPEIMGCTGCQIDWKKGKNVTLKTIKKKQKHKGRGTVRTVTKT |
| A0A8D0QPG4 |
- |
K21 |
*****IAALDPNLKRRVNALKNLQVKCAQIEAKFYEEVHDLERKYAVLYQP |
| A0A8D0QPG4 |
- |
K39 |
ALKNLQVKCAQIEAKFYEEVHDLERKYAVLYQPLFDKRFEIINAIYEPTEE |
| A0A8D0QQ23 |
Calumenin |
K342 |
DWILPSDYDHAEAEARHLVYESDQNKDGKLTKEEIVDKYDLFVGSQATDFG |
| A0A8D0RDV2 |
Integrin beta |
K385 |
TVGVLSSNSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEV |
| A0A8D0RDV2 |
Integrin beta |
K443 |
VGLKIGDTVSFSIEAKVRGCPREKEKSFTIKPVGFKDSLTVQVTFNCDCDC |
| A0A8D0RDV2 |
Integrin beta |
K448 |
GDTVSFSIEAKVRGCPREKEKSFTIKPVGFKDSLTVQVTFNCDCDCQAQAE |